Los Angeles Capital Management LLC Sells 1,469 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Los Angeles Capital Management LLC cut its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 0.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 154,018 shares of the company's stock after selling 1,469 shares during the quarter. Los Angeles Capital Management LLC owned 0.06% of HCA Healthcare worth $53,221,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of HCA. Sanders Capital LLC grew its stake in HCA Healthcare by 1.0% during the fourth quarter. Sanders Capital LLC now owns 11,655,563 shares of the company's stock worth $3,498,417,000 after purchasing an additional 116,826 shares during the period. Geode Capital Management LLC boosted its position in HCA Healthcare by 1.3% in the fourth quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company's stock worth $1,159,882,000 after purchasing an additional 50,321 shares during the last quarter. Capital World Investors boosted its position in HCA Healthcare by 0.7% in the fourth quarter. Capital World Investors now owns 2,928,452 shares of the company's stock worth $878,975,000 after purchasing an additional 19,121 shares during the last quarter. Norges Bank purchased a new position in shares of HCA Healthcare during the 4th quarter valued at $840,286,000. Finally, Northern Trust Corp lifted its holdings in HCA Healthcare by 12.4% during the 4th quarter. Northern Trust Corp now owns 2,017,971 shares of the company's stock worth $605,694,000 after purchasing an additional 223,248 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares in the company, valued at $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 1.30% of the company's stock.

HCA Healthcare Price Performance

NYSE HCA opened at $360.91 on Friday. The stock's fifty day moving average price is $376.38 and its 200 day moving average price is $344.30. The company has a market cap of $86.82 billion, a price-to-earnings ratio of 16.05, a PEG ratio of 1.27 and a beta of 1.47. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The company had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. During the same period last year, the firm earned $5.36 EPS. The firm's revenue for the quarter was up 5.7% compared to the same quarter last year. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 16th were issued a $0.72 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.80%. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

Wall Street Analysts Forecast Growth

HCA has been the topic of a number of research analyst reports. Morgan Stanley set a $410.00 target price on HCA Healthcare and gave the stock an "equal weight" rating in a research note on Monday, June 9th. Bank of America cut HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price objective for the company. in a report on Wednesday. Stephens upgraded HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Wells Fargo & Company upgraded HCA Healthcare from an "underweight" rating to an "equal weight" rating and raised their target price for the company from $320.00 to $385.00 in a research note on Thursday, May 29th. Finally, Wall Street Zen upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Eight investment analysts have rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $399.21.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.